# Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter

Study · id `cardio:ct-nct01818583` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01818583](<https://clinicaltrials.gov/study/NCT01818583>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01818583

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 143 participants.

## Technical summary

Registry record NCT01818583. Randomized; single masking; primary purpose treatment. Start 2013-03 (actual); primary completion 2017-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 143 participants (enrolled count; ClinicalTrials.gov record NCT01818583, source copy `cardio:ctgov-nct01818583-2018-07-31`, retrieved 2026-10-26)
- Started: 2013-03 (actual) (ClinicalTrials.gov record NCT01818583, source copy `cardio:ctgov-nct01818583-2018-07-31`, retrieved 2026-10-26)
- Primary completion: 2017-11 (actual) (ClinicalTrials.gov record NCT01818583, source copy `cardio:ctgov-nct01818583-2018-07-31`, retrieved 2026-10-26)
- Completion: 2017-11 (actual) (ClinicalTrials.gov record NCT01818583, source copy `cardio:ctgov-nct01818583-2018-07-31`, retrieved 2026-10-26)
- Countries: Norway (ClinicalTrials.gov record NCT01818583, source copy `cardio:ctgov-nct01818583-2018-07-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01818583-2018-07-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Potassium Infusion for Conversion of Atrial Fibrillation/-Flutter
- Condition: Atrial Fibrillation
- Condition: Atrial Flutter
- Intervention (Drug): Potassium chloride
- Intervention (Drug): Glucose 50 MG/ML
- Lead sponsor: Diakonhjemmet Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Potassium infusion increases the likelihood of conversion of recent-onset atrial fibrillation-A single-blinded, randomized clinical trial (`cardio:pubmed-31986288`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 3f580487a301d63f7a1724a26ed417a4a21aee8f680bb954e6862be92f6b9858
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
